Fibromyalgia Therapeutics Global Strategic Business Report 2024-2030 Featuring Allergan, Boehringer Ingelheim, Daiichi Sankyo, Eli Lilly and Co, Innovative Med Concepts, Pfizer, SWITCHBIOTECH, Zynerba
July 22, 2024 10:48 ET
|
Research and Markets
Dublin, July 22, 2024 (GLOBE NEWSWIRE) -- The "Fibromyalgia Therapeutics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
US, Germany and the UK Niemann Pick Type C Opportunity Assessment and Forecast 2021-2023 & 2024-2031 Featuring J&J, Piramal Enterprises, IntraBio, Zevra Therapeutics, Azafaros, & Cyclo Therapeutics
July 19, 2024 06:51 ET
|
Research and Markets
Dublin, July 19, 2024 (GLOBE NEWSWIRE) -- The "Niemann Pick Type C: Opportunity Assessment and Forecast - Update" report has been added to ResearchAndMarkets.com's offering.The prevalence of...
Antivenoms Global Market Insights and Outlook 2024-2030: A $2.3 Billion Opportunity with Snake Antivenoms Accounting for ~87% Share of the Total Market - BTG PLC Leads the Competition, Followed by CSL Ltd.
July 18, 2024 09:08 ET
|
Research and Markets
Dublin, July 18, 2024 (GLOBE NEWSWIRE) -- The "Antivenoms - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Antivenoms is...
Amyotrophic Lateral Sclerosis Opportunity Assessment and Forecasts 2019-2024 & 2024-2029 - Focus on US, France, Germany, Italy, Spain, UK, Japan and Canada
July 17, 2024 09:47 ET
|
Research and Markets
Dublin, July 17, 2024 (GLOBE NEWSWIRE) -- The "Amyotrophic Lateral Sclerosis: Opportunity Assessment and Forecast 2019-2029 - Update" report has been added to ResearchAndMarkets.com's offering.This...
United States Hereditary Angioedema Therapeutics Market Soars to New Heights, Projections to 2029
July 16, 2024 11:22 ET
|
Research and Markets
Dublin, July 16, 2024 (GLOBE NEWSWIRE) -- The "United States Hereditary Angioedema Therapeutics Market, By Region, Competition, Forecast and & Opportunities, 2019-2029F" report has been added to...
Global Glucosamine Business Analysis Report 2024: Market to Reach $1.7 Billion by 2030 from $1.1 Billion in 2023 - Emerging Markets and Growth Opportunities in Developing Regions
July 15, 2024 05:31 ET
|
Research and Markets
Dublin, July 15, 2024 (GLOBE NEWSWIRE) -- The "Glucosamine - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Glucosamine is...
Acute Graft-Versus-Host Disease Pipeline Research 2024 Featuring MaaT Pharma, Medac, CSL Behring, Humanigen, Ironwood Pharmaceuticals, ReAlta Life Sciences, Roche, and Incyte
June 26, 2024 09:34 ET
|
Research and Markets
Dublin, June 26, 2024 (GLOBE NEWSWIRE) -- The "Acute Graft-Versus-Host Disease - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This "Acute...
U.S. Inflammatory Bowel Disease Treatment Market Trends Analysis Report 2024-2030 Featuring Biogen, Novartis, Eli Lilly & Co, UCB, Celltrion, Merck & Co, and Johnson & Johnson
June 25, 2024 10:57 ET
|
Research and Markets
Dublin, June 25, 2024 (GLOBE NEWSWIRE) -- The "U.S. Inflammatory Bowel Disease Treatment Market Size, Share & Trends Analysis Report by Type, Drug Class, Route Of Administration, Distribution...
$10.9 Billion Attention Deficit Hyperactivity Disorder (ADHD) Opportunity Assessment and Forecasts 2022-2024 & 2032: Epidemiology, Symptoms, Diagnosis, Disease Management, Revenue, Unmet Needs
June 20, 2024 04:20 ET
|
Research and Markets
Dublin, June 20, 2024 (GLOBE NEWSWIRE) -- The "Attention Deficit Hyperactivity Disorder (ADHD): Opportunity Assessment and Forecast 2022-2032" report has been added to ResearchAndMarkets.com's...
Fibromyalgia Drug Pipeline Landscape Report 2024 Featuring Tonix Pharmaceuticals, Virios Therapeutics, Tryp Therapeutics, Axsome Therapeutics, Scilex, Silo Pharma,& UCB Biopharma
June 17, 2024 07:33 ET
|
Research and Markets
Dublin, June 17, 2024 (GLOBE NEWSWIRE) -- The "Fibromyalgia - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This Report provides comprehensive insights...